Delivery Order SPE2DB20D1110-SPE2DB24FJ72Y
Award Date 11/7/23
Potential Completion Date 11/8/23
Potential Value $3.3K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $4,530.74, is for the delivery of 1,000 units of the medication Tamsulosin HCL 0.4 mg capsules. The contract has a completion date of October 17, 2023 and is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,120.82, is for the delivery of 1,000 capsules of Tamsulosin HCL 0.4 mg. The contract is a Firm Fixed Price Delivery Order with a completion date of July 26, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,358.17, is for the delivery of Tamsulosin HCL 0.4 mg capsules in quantities of 1,000. It is a Firm Fixed Price Delivery Order contract with a performance period ending on July 26, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,190.28, is for the delivery of 1,000 units of the medication Tamsulosin HCL 0.4 mg capsule. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is January 7, 2025. The contract does not have a set-aside designation, indicating open...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,814.05, is for the delivery of Tamsulosin HCl 0.4 mg capsules in quantities of 1,000. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 28, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,723.34, is for the delivery of 1000 units of the prescription medication Tamsulosin HCL 0.4 mg capsules. This is a firm fixed-price delivery order contract with a completion date of June 5, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,191.36, is for the delivery of 1,000 units of the medication Tamsulosin HCL 0.4 mg capsules. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of March 13, 2025. This award is not designated as a set-aside contract. AmerisourceBergen holds a...
- This federal contract award, valued at $7,111.72, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order for the supply of 1,000 units of Tamsulosin HCL 0.4 mg capsules, a pharmaceutical product used for the treatment of various medical conditions. The contract has an ultimate completion date of October 19, 2023 and is a firm-fixed-price arrangement. Amerisourcebergen...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,699.60, is for the delivery of 1,000 units of the prescription medication Tamsulosin HCL 0.4 mg Capsule. The contract has an ultimate completion date of December 27, 2024 and was awarded on December 26, 2024. It is a firm fixed price delivery order contract with no set-aside designation,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,025.56, is for the delivery of 4,567,240 units of the prescription medication Tamsulosin HCl 0.4 mg capsules. The contract is a Firm Fixed Price Delivery Order that runs through February 12, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen...